Login
Israel-Hamas Conflict
World Cup
Social Media
Boxing
Military
War
Benjamin Netanyahu
South America
Artificial Intelligence
Donald Trump
Natural Disasters
Immigration
Instagram
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

New Study: GLP-1 Medications Decrease Risk of Major Cardiovascular Events

Summary by DAIC
Study show GLP-1 patients with moderate peripheral artery disease are less susceptible to cardiovascular events and amputations.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
DAICDAIC

New Study: GLP-1 Medications Decrease Risk of Major Cardiovascular Events

Study show GLP-1 patients with moderate peripheral artery disease are less susceptible to cardiovascular events and amputations.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

DAIC broke the news in on Friday, June 6, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

New Orleans

New Orleans

News
For You
SearchBlindspotLocal